Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,470 across all filing types
Latest filing 2024-12-23 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a comprehensive circular to shareholders of Sinopharm Tech Holdings Limited containing the notice of the Annual General Meeting, proposals for general mandates to issue and repurchase shares, re-election of directors, explanatory appendices, and proxy instructions. It is essentially a proxy solicitation and information statement for an AGM rather than the report itself or a standalone announcement of results. Therefore, it best fits the Proxy Solicitation & Information Statement category (PSI).
2024-12-23 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a statutory notice of the Company’s Annual General Meeting including the full agenda of ordinary and special resolutions, proxy instructions and details on how to vote. It is not the full annual report or meeting minutes, nor is it a post‐meeting voting result. Rather, it is sent to shareholders to provide information on the meeting and solicit their votes (including proxy forms). This aligns with the Proxy Solicitation & Information Statement category (PSI).
2024-12-23 English
ANNUAL REPORT 2024
Annual Report Classification · 100% confidence The document is explicitly titled 'ANNUAL REPORT 2024' for Sinopharm Tech Holdings Limited. It contains comprehensive sections including Corporate Information, Management Discussion and Analysis, Financial Review, and references to the Consolidated Financial Statements. It covers the full fiscal year ending 30 June 2024, fitting the definition of an Annual Report (10-K). FY 2024
2024-12-23 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 30 JUNE 2024 AND RESUMPTION OF TRADING
Annual Report Classification · 100% confidence The document is the 'Annual Report 2024' for Sinopharm Tech Holdings Limited. It contains comprehensive financial statements, management discussion and analysis, auditor's reports, and corporate governance information for the fiscal year ended 30 June 2024. Although it includes an 'Annual Results Announcement' at the beginning, the document continues into the full annual report content, making it a complete annual report filing. FY 2024
2024-12-23 English
POSTPONEMENT OF DATE OF BOARD MEETING
Regulatory Filings Classification · 82% confidence The document is a corporate announcement regarding the postponement of a scheduled Board meeting date. It does not present any financial results, voting outcomes, dividend details, or management changes; rather, it updates shareholders with regulatory-required information. It is not itself a director change notice nor a detailed report but a regulatory filing announcement. Therefore, it falls under the general Regulatory Filings category (RNS).
2024-12-11 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2024
Regulatory Filings Classification · 98% confidence The document is a monthly return (Form FF301) filed by a Hong Kong–listed issuer to the Hong Kong Exchange under Listing Rule Chapter 19B, detailing movements in authorised, issued, and treasury share capital for the month. It is not an AGM presentation, earnings release, annual or interim report, nor a specific single capital-raising announcement. Instead, it is a routine regulatory submission summarizing various share capital changes. No other precise category matches this regular listing‐rule return, so it should be classified under the fallback “Regulatory Filings” (RNS).
2024-12-05 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.